Kaitlin M. Kestenberg-Messina insider trades: Adma Biologics (ADMA) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Kaitlin reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 9, 2026 | ADMA | ↓ Sell | 10,096 | $15.63 | $158K | Direct | Mar 10, 2026 (1d) |
| Aug 30, 2024 | ADMA | ↓ Sell | 24,150 | $16.90 | $408K | Direct | Aug 30, 2024 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ADMA insiders
Open-market trades in the last 12 months
About Kaitlin M. Kestenberg-Messina's insider trades
Kaitlin M. Kestenberg-Messina is COO and SVP, Compliance at Adma Biologics (ADMA). Since Aug 30, 2024, Kaitlin has reported no open-market purchases and 2 sales worth $566K on SEC Form 4. In the last 12 months: 1 sale ($158K).
Their filings also include shares withheld for taxes (14 filings), option exercises (4 filings), grants and awards (3 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ADMA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.